Liabilities / Assets
15th percentile
Higher debt load relative to assets than 15% of similar nonprofits.
Benign Essential Blepharospasm Research Foundation Inc.
990 • Fiscal year 2013 • EIN 74-2193322
Siviq Scores
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
0.00x
Liabilities / Revenue
19th percentile
Higher debt load relative to revenue than 19% of similar nonprofits.
Net Margin
6th percentile
Higher net margin than 6% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
15th percentile
Faster asset growth than 15% of similar nonprofits.
Revenue Growth
4th percentile
Faster revenue growth than 4% of similar nonprofits.
Balance Sheet
Assets
Down$1,680,190
Down $138,863 (-7.6%) from 2012
Net Assets
Down$1,678,815
Down $138,836 (-7.6%) from 2012
Liabilities
Down$1,375
Down $27 (-1.9%) from 2012
Revenue And Expenses
Revenue
Down$275,714
Down $297,930 (-52%) from 2012
Expenses
Up$414,553
Up $170,662 (+70%) from 2012
Net Income
Down-$138,839
Down $468,592 (-142%) from 2012
Historical Trend
Filing Detail Status
This 2013 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
Jump To
Filing Snapshot
- Filing Period
- Jan 1, 2013 to Dec 31, 2013
Mission and Program Overview
Mission
Education and research pertaining to benign essential blepharospasm and related conditions
Document Assets
No mirrored PDF or thumbnail assets are attached yet.
Filings
Displayed year
2013 • Form 990Summary only. Only limited summary data is available for this year.
- Assets
- $1,680,190
- Liabilities
- $1,375
- Net assets
- $1,678,815
- Revenue
- $275,714
- Expenses
- $414,553
- Net income
- -$138,839